Briefly blocking a key molecule when administering the only approved vaccine for tuberculosis vastly improves long-term protection against the devastating disease in mice, researchers from Texas Biomedical Research… read more.
Open discussion of the scientific evidence and the uncertainties could have generated less political polarisation, less wasted expenditure but built more trust, according to Allyson Pollock, Clinical Professor… read more.
Covid is far less serious for children, long-covid is not a big issue and many also have natural immunity – all of which raises questions over whether children… read more.
There are several theoretical reasons for implementing vaccine passports but now that none of these apply any longer in the UK it is difficult to see a rationale… read more.
Many factors influence decisions about vaccine use including many ‘unknowns’ and this raises questions about the wisdom of targeting young people and recommending boosters for everyone, explains Allyson… read more.
There was no evidence that mass testing stopped or prevented the transmission of covid-19, according to Professor Allyson Pollock, Clinical Professor of Public Health, Newcastle University. “Mass testing… read more.
An analysis of the records more than 41,000 patients who had covid-19 and were treated with either ivermectin or remdesivir showed that ivermectin was associated with significantly lower… read more.
As the coronavirus pandemic appears to be running out of steam it is important to review the lessons learned and move forward to ‘living with the virus’. IMI… read more.
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus… read more.
90% of respondents supported revocation of the vaccine mandate, in a public consultation exercise carried out in February 2022. The UK Government has today (March 1st) published its… read more.
Moderna, Inc., announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna’s mRNA COVID-19 vaccine, Spikevax, in a 50 µg… read more.
A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
